VRXA CIK: 2079109

Veraxa Biotech AG - Post de-SPAC

  • Germany
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
millions CHF
FY23:
–
FY24:
0
FY25:
0.02
(positive)
Change from FY23 to FY25
millions CHF
FY23:
−16.7
FY24:
−28.9
FY25:
−66.2
(positive)
Change from FY23 to FY25
millions CHF
FY23:
−14.8
FY24:
−27.0
FY25:
−64.1
(positive)
Change from FY23 to FY25
millions CHF
FY23:
−17.7
FY24:
−28.8
FY25:
−67.0
(positive)
Change from FY23 to FY25
millions CHF
FY23:
−16.5
FY24:
−28.1
FY25:
−66.6

All amounts in millions CHF Data source:Twelve Data